Showing results (1431-1440 of 1,731) with videos related to

Sort By:
Pageof 174
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Human Pathology|June 8, 2021
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumorsAnne Menz, Rifka Bauer, Martina Kluth, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis|September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancerSimon Kind, Annika Jaretzke, Franziska Büscheck, et al.
The Journal of Physiology|April 11, 2018
Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinicJanna L Morrison, Kimberley J Botting, Jack R T Darby, et al.
Environmental Health Perspectives|March 23, 2004
Identification of putative gene based markers of renal toxicityRupesh P Amin, Alison E Vickers, Frank Sistare, et al.
Diagnostic and Interventional Imaging|June 8, 2025
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancerGhina Jardali, Littisha Lawrance, Lama Dawi, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 21, 2022
Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumorsMaximilian Lennartz, Verena Sofia Ullmann, Natalia Gorbokon, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Pageof 174